FDA Approves Blujepa (Gepotidacin): First New Oral Antibiotic for uUTIs in Nearly 30 YearsGSK’s Blujepa (gepotidacin) has received FDA approval for the treatment of uncomplicated urinary tract infections (uUTIs) in females aged 12 and above (≥40 kg). This marks the first approval in a new class of oral antibiotics for uUTIs in nearly three decades, targeting an urgent public health need amidst rising antimicrobial resistance.
on
March 28, 2025
Lorundrostat Shows Promise in Treating Uncontrolled Hypertension in Pivotal Trials‍Lorundrostat, a novel aldosterone synthase inhibitor developed by Mineralys Therapeutics, has demonstrated significant blood pressure reductions in two pivotal hypertension trials, according to the company’s announcement. The drug targets uncontrolled and resistant hypertension, which affects approximately 20 million people in the U.S. alone.
on
March 17, 2025
Kerala School Reports Viral Meningitis Cases, Health Authorities on High AlertFive students from classes 1 and 2 at St. Paul’s International School, Kalamassery, in Kerala’s Ernakulam district have been hospitalized after exhibiting symptoms consistent with viral meningitis, raising alarms among health authorities.
on
March 13, 2025
DCGI’s Renewed Mandate: Wiping Out Substandard Drugs, Supporting MSMEs, and Regulating Medical DevicesThe Drugs Controller General of India (DCGI), Rajeev Singh Raghuvanshi, has been granted a one-year extension to lead India’s apex drug regulatory body, focusing on eliminating substandard drugs, upgrading MSME pharmaceutical standards, and integrating medical device regulations.
on
March 12, 2025
Delhi Sees Surge in H1N1 and Influenza B CasesDelhi is witnessing a sharp rise in seasonal flu cases, with H1N1 (swine flu) and Influenza B leading to prolonged respiratory infections. A survey by LocalCircles found that 54% of households reported symptoms such as fever, sore throat, cough, headache, stomach troubles, and joint pain.
on
March 11, 2025

Featured

FDA Approves Blujepa (Gepotidacin): First New Oral Antibiotic for uUTIs in Nearly 30 Years
Lorundrostat Shows Promise in Treating Uncontrolled Hypertension in Pivotal Trials
Kerala School Reports Viral Meningitis Cases, Health Authorities on High Alert
DCGI’s Renewed Mandate: Wiping Out Substandard Drugs, Supporting MSMEs, and Regulating Medical Devices
Delhi Sees Surge in H1N1 and Influenza B Cases

Participate in India’s healthcare revolution

Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)

Create ABHA ID

Popular topics

#

newfeature

#

Partnership

#

funding